静脉动脉外体生命支持在循环休克中的循环休克二次到严重的血管,由拉米普利尔过量服用
Johan van Nispen1, Gabrielle Bradley2, Mindaugas Rackauskas1
1Department of Surgery, University of Florida, Division of Thoracic and Cardiovascular Surgery, FL, USA.
Annals of cardiac anaesthesia
|October 13, 2025
概括
管理血管激素转化酶抑制剂 (ACEI) 过量是很困难的. 本案例研究表明,使用静脉外体生命支持成功管理,为ACEI毒性提供了一种新的治疗方法.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 血管激素转化酶抑制剂 (ACEI) 过量剂量的管理存在重大临床挑战.
- 对于ACEI过量服用的传统治疗策略的有效性有限.
研究的目的:
- 介绍一个成功的ACEI过量管理的新案例.
- 探索静脉脉外体生命支持 (VA-ECLS) 在ACEI毒性的使用.
主要方法:
- 一个病例报告详细介绍了ACEI过量服用的临床过程.
- 静脉外体生命支持 (VA-ECLS) 作为治疗干预的应用.
主要成果:
- 一个患有严重ACEI过量剂量的患者的成功复苏和稳定.
- 证明VA-ECLS作为耐火性ACEI毒性的可行治疗方式.
结论:
- 静脉动脉外体生命支持为严重的ACEI过量提供了一个有前途的新疗法选择.
- 需要进一步的研究来阐明VA-ECLS在管理ACEI诱导的心血管崩中的作用.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
1.5K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.5K
Cardiopulmonary Resuscitation IV: Pharmacological Management
655
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
655
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
176
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
176
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
188
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
188
Continuous Renal Replacement Therapy
831
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
831
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468


